APO LMV 300 Pill - gray four-sided, 18mm
Pill with imprint APO LMV 300 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Apotex Inc.
Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LMV 300
Lamivudine
- Imprint
- APO LMV 300
- Strength
- 300 mg
- Color
- Gray
- Size
- 18.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Inc.
- National Drug Code (NDC)
- 60505-3252
- Inactive Ingredients
-
ferrosoferric oxide,
lactose anhydrous,
crospovidone,
silicon dioxide,
hypromelloses,
hydroxypropyl cellulose,
magnesium stearate,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
